Europe Acute Myeloid Leukemia Diagnostics Market - Industry Trends and Forecast to 2033
Europe acute myeloid leukemia diagnostics market is projected to register a substantial CAGR of 10.8% in the forecast period of 2024 to 2031. The new market report contains data for the historic year 2022, the base year of calculation is 2023, and the forecast period is 2024 to 2031.
Market Segmentation
EUROPE Acute Myeloid Leukemia Diagnostics Market, By Product Type (Instruments, and Consumables & Accessories), Test Type (Imaging Test, Blood Test, Bone Marrow Test, Biomarker Test, Immunophenotyping, Genetic Testing and Others), Cancer Type (Myeloblastic (M0), Myeloblastic (M1), Myeloblastic (M2), Promyelocytic (M3), Myelomonocytic (M4), MONOCYTIC (M5), Erythroleukemia (M6) and Megakaryocytic (M7)), Age Group (Below 21, 21-29, 30-65, 65 and Above), Gender (Male and Female) End User (Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, and Others), Distribution Channel (Direct Tender, Retail Sales) Country, ( Europe, Germany, France, U.K., Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, and Rest of Europe) - Industry Trends and Forecast to 2031
Driver
• Increasing diagnostic products for leukemia cancer
Restrain
• Late diagnosis and Poor prognosis of leukemia
Opportunity
• Initiatives by government and other authorities for life sciences and funding
Market Players
Some of the major market players in Europe acute myeloid leukemia diagnostics market are:
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific, Inc.
• QIAGEN
• Abbott
• Siemens Healthcare GmbH
• Hologic, Inc.
• Agilent Technologies, Inc.
• DiaSorin S.p.A.
• Illumina, Inc.
• BIOMÉRIEUX
• Myriad Genetics, Inc.
• Quest Diagnostics Incorporated.
• Bio-Rad Laboratories, Inc.
• Koninklijke Philips N.V.
• BD
• Exact Sciences Corporation
• Time Medical Holding
• PlexBio
• MinFound Medical Systems Co., Ltd
• Medonica Co. LTD
• CANON MEDICAL SYSTEMS CORPORATION
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of The Europe Acute Myeloid Leukemia Diagnostics Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Product Type Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Market End User Coverage Grid
- 2.11 Vendor Share Analysis
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Executive Summary
- 4 Premium Insights
- 4.1 Pestel Analysis
- 4.2 Porter’s Five Forces
- 4.3 Epidemiology
- 5 Europe Acute Myeloid Leukemia Diagnostics Market, Regulations
- 5.1 Regulatory Scenario In The U.S.
- 5.2 Regulatory Scenario In Australia
- 5.3 Regulatory Scenario In Japan
- 5.4 Regulatory Scenario In China
- 6 Market Overview
- 6.1 Drivers
- 6.1.1 Growing Prevalence Of Leukemia Cancer
- 6.1.2 Novel Technological Advancements In Leukemia Diagnostics
- 6.1.3 Rising Preference For Preventive Health Check-ups
- 6.1.4 Increase In Awareness Regarding Leukemia Cancer
- 6.2 Restraints
- 6.2.1 Strict Regulations And Standards For The Approval And Commercialization Of Leukemia Diagnostic Products
- 6.2.2 Late Diagnosis And Poor Prognosis Of Leukemia
- 6.3 Opportunities
- 6.3.1 Increase In Diagnostic Products For Leukemia
- 6.3.2 Rise In Healthcare Expenditure For Cancer Diagnosis And Treatment
- 6.3.3 Government Initiatives Toward Cancer Diagnostics
- 6.4 Challenges
- 6.4.1 Increased Cost, Safety, And Convenience Issues
- 6.4.2 Lack Of Skilled And Certified Professionals
- 7 Europe Acute Myeloid Leukemia Diagnostics Market, By Product Type
- 7.1 Overview
- 7.2 Instruments
- 7.2.1 Biopsy Instruments
- 7.2.1.1 Bone Marrow Biopsy
- 7.2.1.2 Needle Biopsy
- 7.2.1.3 Surgical Biopsy
- 7.2.1.4 Others
- 7.2.2 Pathology-based Instruments
- 7.2.2.1 Pcr Instruments
- 7.2.2.2 Slide Staining Systems
- 7.2.2.3 Tissue Processing Systems
- 7.2.2.4 Cell Processors
- 7.2.2.5 Other Pathology-based Instruments
- 7.2.3 Imaging Instruments
- 7.2.3.1 Ultrasound Systems
- 7.2.3.2 Ct Systems
- 7.2.3.3 Mri Systems
- 7.2.3.4 Others
- 7.2.4 Others
- 7.3 Consumables & Accessories
- 7.3.1 Kits
- 7.3.1.1 Pcr Kits
- 7.3.1.2 Dna Polymerase Kits
- 7.3.1.3 Nucleic Acid Isolation Kits
- 7.3.1.4 Others
- 7.3.2 Reagents
- 7.3.2.1 Assays
- 7.3.2.2 Buffers
- 7.3.2.3 Primers
- 7.3.2.4 Others
- 7.3.3 Probes
- 7.3.4 Other Consumables
- 8 Europe Acute Myeloid Leukemia Diagnostics Market, By Test Type
- 8.1 Overview
- 8.2 Blood Test
- 8.2.1 Complete Blood Count (Cbc)
- 8.2.2 Blood Chemistry Tests
- 8.2.3 Others
- 8.3 Imaging Test
- 8.3.1 Computed Tomography (Ct) Scan
- 8.3.2 Mri
- 8.3.3 Positron Emission Tomography (Pet) Scan
- 8.3.4 Others
- 8.4 Bone Marrow Tests
- 8.4.1 Bone Marrow Aspirate
- 8.4.2 Bone Marrow Biopsy
- 8.4.3 Others
- 8.5 Genetic Tests
- 8.5.1 Fluorescence In Situ Hybridization (Fish)
- 8.5.2 Karyotyping
- 8.5.3 Others
- 8.6 Biomarker Test
- 8.6.1 Genetic Acute Myeloid Leukemia (Aml) Biomarker
- 8.6.2 Epigenetic Acute Myeloid Leukemia (Aml) Biomarker
- 8.6.3 Proteomic Acute Myeloid Leukemia (Aml) Biomarker
- 8.7 Immunophenotyping
- 8.7.1 Flow Cytometry
- 8.7.2 Immunohistochemistry
- 8.7.3 Others
- 8.8 Others
- 9 Europe Acute Myeloid Leukemia Diagnostics Market, By Cancer Type
- 9.1 Overview
- 9.2 Myeloblastic (M0)
- 9.3 Myeloblastic (M1)
- 9.4 Myeloblastic (M2)
- 9.5 Promyelocytic (M3)
- 9.6 Myelomonocytic (M4)
- 9.7 Monocytic (M5)
- 9.8 Erythroleukemia (M6)
- 9.9 Megakaryocytic (M7)
- 10 Europe Acute Myeloid Leukemia Diagnostics Market, By Age Group
- 10.1 Overview
- 10.2 65 And Above
- 10.3 30-65
- 10.4 Below 21
- 10.5 21-29
- 11 Europe Acute Myeloid Leukemia Diagnostics Market, By Gender
- 11.1 Overview
- 11.2 Male
- 11.3 Female
- 12 Europe Acute Myeloid Leukemia Diagnostics Market, By End User
- 12.1 Overview
- 12.2 Hospitals
- 12.3 Associated Labs
- 12.4 Independent Diagnostic Laboratories
- 12.5 Diagnostic Imaging Centers
- 12.6 Cancer Research Institutes
- 12.7 Others
- 13 Europe Acute Myeloid Leukemia Diagnostics Market, By Distribution Channel
- 13.1 Overview
- 13.2 Direct Tender
- 13.3 Retail Sales
- 14 Europe Acute Myeloid Leukemia Diagnostics Market, By Region
- 14.1 Europe
- 14.1.1 Germany
- 14.1.2 United Kingdom
- 14.1.3 France
- 14.1.4 Italy
- 14.1.5 Spain
- 14.1.6 Russia
- 14.1.7 Netherlands
- 14.1.8 Switzerland
- 14.1.9 Belgium
- 14.1.10 Turkey
- 14.1.11 Rest Of Europe
- 15 Europe Acute Myeloid Leukemia Diagnostics Market: Company Landscape
- 15.1 Company Share Analysis: Europe
- 16 Swot Analysis
- List Of Tables
- Table 1 Approved Diagnostics Of Leukemia
- Table 2 Europe Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 3 Europe Instruments In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 4 Europe Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 5 Europe Biopsy Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 6 Europe Pathology-based Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 7 Europe Imaging Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 8 Europe Consumables & Accessories In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 9 Europe Consumables & Accessories In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 10 Europe Kits In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 11 Europe Reagents In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 12 Europe Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 13 Europe Blood Test In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 14 Europe Blood Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 15 Europe Imaging Test In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 16 Europe Imaging Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 17 Europe Bone Marrow Tests In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 18 Europe Bone Marrow Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 19 Europe Genetic Tests In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 20 Europe Genetic Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 21 Europe Biomarker Test In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 22 Europe Biomarker Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 23 Europe Immunophenotyping In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 24 Europe Immunophenotyping In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 25 Europe Others In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 26 Europe Acute Myeloid Leukemia Diagnostics Market, By Cancer Type, 2022-2031 (Usd Million)
- Table 27 Europe Myeloblastic (M0) In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 28 Europe Myeloblastic (M1) In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 29 Europe Myeloblastic (M2) In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 30 Europe Promyelocytic (M3) In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 31 Europe Myelomonocytic (M4) In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 32 Europe Monocytic (M5) In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 33 Europe Erythroleukemia (M6) In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 34 Europe Megakaryocytic (M7) Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 35 Europe Acute Myeloid Leukemia Diagnostics Market, By Age Group, 2022-2031 (Usd Million)
- Table 36 Europe 65 And Above In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 37 Europe 30-65 In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 38 Europe Below 21 In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 39 Europe 21-29 In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 40 Europe Acute Myeloid Leukemia Diagnostics Market, By Gender, 2022-2031 (Usd Million)
- Table 41 Europe Male In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 42 Europe Female In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 43 Europe Acute Myeloid Leukemia Diagnostics Market, By End User, 2022-2031 (Usd Million)
- Table 44 Europe Hospitals In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 45 Europe Associated Labs In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 46 Europe Independent Diagnostic Laboratories In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 47 Europe Diagnostic Imaging Centers In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 48 Europe Cancer Research Institutes In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 49 Europe Others In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 50 Europe Acute Myeloid Leukemia Diagnostics Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 51 Europe Direct Tender In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 52 Europe Retail Sales In Acute Myeloid Leukemia Diagnostics Market, By Region, 2022-2031 (Usd Million)
- Table 53 Europe Acute Myeloid Leukemia Diagnostics Market, By Country, 2022-2031 (Usd Million)
- Table 54 Europe Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 55 Europe Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 56 Europe Biopsy Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 57 Europe Pathology-based Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 58 Europe Imaging Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 59 Europe Consumables & Accessories In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 60 Europe Kits In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 61 Europe Reagents In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 62 Europe Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 63 Europe Blood Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 64 Europe Imaging Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 65 Europe Bone Marrow Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 66 Europe Genetic Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 67 Europe Biomarker Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 68 Europe Immunophenotyping In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 69 Europe Acute Myeloid Leukemia Diagnostics Market, By Cancer Type, 2022-2031 (Usd Million)
- Table 70 Europe Acute Myeloid Leukemia Diagnostics Market, By Age Group, 2022-2031 (Usd Million)
- Table 71 Europe Acute Myeloid Leukemia Diagnostics Market, By Gender, 2022-2031 (Usd Million)
- Table 72 Europe Acute Myeloid Leukemia Diagnostics Market, By End User, 2022-2031 (Usd Million)
- Table 73 Europe Acute Myeloid Leukemia Diagnostics Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 74 Germany Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 75 Germany Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 76 Germany Biopsy Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 77 Germany Pathology-based Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 78 Germany Imaging Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 79 Germany Consumables & Accessories In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 80 Germany Kits In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 81 Germany Reagents In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 82 Germany Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 83 Germany Blood Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 84 Germany Imaging Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 85 Germany Bone Marrow Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 86 Germany Genetic Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 87 Germany Biomarker Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 88 Germany Immunophenotyping In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 89 Germany Acute Myeloid Leukemia Diagnostics Market, By Cancer Type, 2022-2031 (Usd Million)
- Table 90 Germany Acute Myeloid Leukemia Diagnostics Market, By Age Group, 2022-2031 (Usd Million)
- Table 91 Germany Acute Myeloid Leukemia Diagnostics Market, By Gender, 2022-2031 (Usd Million)
- Table 92 Germany Acute Myeloid Leukemia Diagnostics Market, By End User, 2022-2031 (Usd Million)
- Table 93 Germany Acute Myeloid Leukemia Diagnostics Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 94 United Kingdom Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 95 United Kingdom Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 96 United Kingdom Biopsy Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 97 United Kingdom Pathology-based Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 98 United Kingdom Imaging Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 99 United Kingdom Consumables & Accessories In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 100 United Kingdom Kits In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 101 United Kingdom Reagents In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 102 United Kingdom Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 103 United Kingdom Blood Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 104 United Kingdom Imaging Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 105 United Kingdom Bone Marrow Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 106 United Kingdom Genetic Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 107 United Kingdom Biomarker Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 108 United Kingdom Immunophenotyping In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 109 United Kingdom Acute Myeloid Leukemia Diagnostics Market, By Cancer Type, 2022-2031 (Usd Million)
- Table 110 United Kingdom Acute Myeloid Leukemia Diagnostics Market, By Age Group, 2022-2031 (Usd Million)
- Table 111 United Kingdom Acute Myeloid Leukemia Diagnostics Market, By Gender, 2022-2031 (Usd Million)
- Table 112 United Kingdom Acute Myeloid Leukemia Diagnostics Market, By End User, 2022-2031 (Usd Million)
- Table 113 United Kingdom Acute Myeloid Leukemia Diagnostics Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 114 France Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 115 France Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 116 France Biopsy Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 117 France Pathology-based Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 118 France Imaging Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 119 France Consumables & Accessories In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 120 France Kits In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 121 France Reagents In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 122 France Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 123 France Blood Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 124 France Imaging Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 125 France Bone Marrow Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 126 France Genetic Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 127 France Biomarker Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 128 France Immunophenotyping In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 129 France Acute Myeloid Leukemia Diagnostics Market, By Cancer Type, 2022-2031 (Usd Million)
- Table 130 France Acute Myeloid Leukemia Diagnostics Market, By Age Group, 2022-2031 (Usd Million)
- Table 131 France Acute Myeloid Leukemia Diagnostics Market, By Gender, 2022-2031 (Usd Million)
- Table 132 France Acute Myeloid Leukemia Diagnostics Market, By End User, 2022-2031 (Usd Million)
- Table 133 France Acute Myeloid Leukemia Diagnostics Market, By Distribution Channel, 2022-2031 (Usd Million)
- Table 134 Italy Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 135 Italy Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 136 Italy Biopsy Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 137 Italy Pathology-based Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 138 Italy Imaging Instruments In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 139 Italy Consumables & Accessories In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 140 Italy Kits In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 141 Italy Reagents In Acute Myeloid Leukemia Diagnostics Market, By Product Type, 2022-2031 (Usd Million)
- Table 142 Italy Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 143 Italy Blood Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 144 Italy Imaging Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 145 Italy Bone Marrow Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 146 Italy Genetic Tests In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 147 Italy Biomarker Test In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 148 Italy Immunophenotyping In Acute Myeloid Leukemia Diagnostics Market, By Test Type, 2022-2031 (Usd Million)
- Table 149 Italy Acute Myeloid Leukemia Diagnostics Market, By Cancer Type, 2022-2031 (Usd Million)
- List Of Figures
- Figure 1 Europe Acute Myeloid Leukemia Diagnostics Market: Segmentation
- Figure 2 Europe Acute Myeloid Leukemia Diagnostics Market: Data Triangulation
- Figure 3 Europe Acute Myeloid Leukemia Diagnostics Market: Droc Analysis
- Figure 4 Europe Acute Myeloid Leukemia Diagnostics Market: Europe Vs Regional Market Analysis
- Figure 5 Europe Acute Myeloid Leukemia Diagnostics Market: Company Research Analysis
- Figure 6 Europe Acute Myeloid Leukemia Diagnostics Market: Interview Demographics
- Figure 7 Europe Acute Myeloid Leukemia Diagnostics Market : Dbmr Market Position Grid
- Figure 8 Europe Acute Myeloid Leukemia Diagnostics Market: Market End User Coverage Grid
- Figure 9 Europe Acute Myeloid Leukemia Diagnostics Market: Vendor Share Analysis
- Figure 10 Europe Acute Myeloid Leukemia Diagnostics Market: Segmentation
- Figure 11 The Growing Prevalence Of Leukemia Cancer Is Expected To Drive The Europe Acute Myeloid Leukemia Diagnostics Market In The Forecast Period
- Figure 12 The Instruments Segment Is Expected To Account For The Largest Share Of The Europe Acute Myeloid Leukemia Diagnostics Market In 2024 & 2031
- Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The Europe Acute Myeloid Leukemia Diagnostics Market
- Figure 14 Number Of Prevalence Of Leukemia Incidence Worldwide (Both Sexes)
- Figure 15 Five Years Prevalence Leukemia Incidence Worldwide (Both Sexes)
- Figure 16 Europe Acute Myeloid Leukemia Diagnostics Market: By Product Type, 2023
- Figure 17 Europe Acute Myeloid Leukemia Diagnostics Market: By Product Type, 2024-2031 (Usd Million)
- Figure 18 Europe Acute Myeloid Leukemia Diagnostics Market: By Product Type, Cagr (2024-2031)
- Figure 19 Europe Acute Myeloid Leukemia Diagnostics Market: By Product Type, Lifeline Curve
- Figure 20 Europe Acute Myeloid Leukemia Diagnostics Market: By Test Type, 2023
- Figure 21 Europe Acute Myeloid Leukemia Diagnostics Market: By Test Type, 2024-2031 (Usd Million)
- Figure 22 Europe Acute Myeloid Leukemia Diagnostics Market: By Test Type, Cagr (2024-2031)
- Figure 23 Europe Acute Myeloid Leukemia Diagnostics Market: By Test Type, Lifeline Curve
- Figure 24 Europe Acute Myeloid Leukemia Diagnostics Market: By Cancer Type, 2023
- Figure 25 Europe Acute Myeloid Leukemia Diagnostics Market: By Cancer Type, 2024-2031 (Usd Million)
- Figure 26 Europe Acute Myeloid Leukemia Diagnostics Market: By Cancer Type, Cagr (2024-2031)
- Figure 27 Europe Acute Myeloid Leukemia Diagnostics Market: By Cancer Type, Lifeline Curve
- Figure 28 Europe Acute Myeloid Leukemia Diagnostics Market: By Age Group, 2023
- Figure 29 Europe Acute Myeloid Leukemia Diagnostics Market: By Age Group, 2024-2031 (Usd Million)
- Figure 30 Europe Acute Myeloid Leukemia Diagnostics Market: By Age Group, Cagr (2024-2031)
- Figure 31 Europe Acute Myeloid Leukemia Diagnostics Market: By Age Group, Lifeline Curve
- Figure 32 Europe Acute Myeloid Leukemia Diagnostics Market: By Gender, 2023
- Figure 33 Europe Acute Myeloid Leukemia Diagnostics Market: By Gender, 2024-2031 (Usd Million)
- Figure 34 Europe Acute Myeloid Leukemia Diagnostics Market: By Gender, Cagr (2024-2031)
- Figure 35 Europe Acute Myeloid Leukemia Diagnostics Market: By Gender, Lifeline Curve
- Figure 36 Europe Acute Myeloid Leukemia Diagnostics Market: By End User, 2023
- Figure 37 Europe Acute Myeloid Leukemia Diagnostics Market: By End User, 2024-2031 (Usd Million)
- Figure 38 Europe Acute Myeloid Leukemia Diagnostics Market: By End User, Cagr (2024-2031)
- Figure 39 Europe Acute Myeloid Leukemia Diagnostics Market: By End User, Lifeline Curve
- Figure 40 Europe Acute Myeloid Leukemia Diagnostics Market: By Distribution Channel, 2023
- Figure 41 Europe Acute Myeloid Leukemia Diagnostics Market: By Distribution Channel, 2024-2031 (Usd Million)
- Figure 42 Europe Acute Myeloid Leukemia Diagnostics Market: By Distribution Channel, Cagr (2024-2031)
- Figure 43 Europe Acute Myeloid Leukemia Diagnostics Market: By Distribution Channel, Lifeline Curve
- Figure 44 Europe Acute Myeloid Leukemia Diagnostics Market: Snapshot (2023)
- Figure 45 Europe Acute Myeloid Leukemia Diagnostics Market: Company Share 2023(%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook